The anthracyclines doxorubicin (A) and epirubicin (E) are among the most active agents for breast cancer.
Patrick G. Morris, MSc
Advertisement
Articles by Patrick G. Morris, MSc
Advertisement
Latest Updated Articles
- Anthracyclines Are a Critical Component of Adjuvant Chemotherapy
Published: February 18th 2011 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
What Were the Key Presentations at ESMO 2025? Oncology Experts Discuss
2
An Oncodermatologist’s Perspective on Dermatological Toxicities in Breast Cancer
3
Porustobart/Tislelizumab Elicits Responses in MSS Metastatic Colorectal Cancer
4
What Path to Approval Has Dasatinib Taken in CML/ALL?
5
